Carbohydrate Restriction and Prostate Cancer Growth (CAPS2)
A Randomized Controlled Clinical Trial of Carbohydrate Restriction Among Men With A Rising PSA After Failed Primary Therapy for Prostate Cancer
Sponsor: Cedars-Sinai Medical Center
A NA clinical study on Prostate Cancer, this trial is completed. The trial is conducted by Cedars-Sinai Medical Center and has accumulated 7 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Nov 2018 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cedars-Sinai Medical Center
- Duke University
- Durham VA Medical Center
- National Cancer Institute (NCI)
- National Institutes of Health (NIH)
- Robert C. Atkins Foundation
For direct contact, visit the study record on ClinicalTrials.gov .